Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Smith-Magenis Syndrome
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Acute Myeloid Leukemia (AML)
Journal:
Annals of hematology
Treatment Used:
Decitabine
Number of Patients:
178
Published —
June 07, 2020
This study evaluated the outcomes of chromosome 17p loss or TP53 gene mutations in older, unfit patients with acute myeloid leukemia (AML) treated with decitabine (DAC).
Condition:
Chronic Lymphocytic Leukemia
Journal:
Leukemia research
Treatment Used:
Ibrutinib
Number of Patients:
1729
Published —
March 02, 2020
The study researched the outcomes of ibrutinib in treating chronic lymphocytic leukemia.
Condition:
Sleep in Children with Autism Spectrum Disorder
Journal:
Journal of autism and developmental disorders
Treatment Used:
Pediatric Prolonged-Release Melatonin
Number of Patients:
125
Published —
May 13, 2019
This study evaluated the effectiveness and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2-5 mg) in improving sleep duration and onset in children aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia.
Condition:
Self-injurious Behaviors in Children with Neurodevelopmental Disorders (NDDs)
Journal:
Pharmacotherapy
Treatment Used:
Behavior Therapies and Pharmocotherapy
Number of Patients:
0
Published —
February 23, 2019
This article discusses the management of self-injurious behaviors in children with neurodevelopmental (NDDs) disorders.
Condition:
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Journal:
Blood
Treatment Used:
Duvelisib vs, Ofatumumab
Number of Patients:
319
Published —
October 06, 2018
This study compared duvelisib versus ofatumumab monotherapy for patients with relapsed or refractory (RR) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Condition:
Relapsed/refractory deletion 17p chronic lymphocytic leukaemia
Journal:
British journal of haematology
Treatment Used:
Ibrutinib
Number of Patients:
230
Published —
June 07, 2018
This study evaluated the clinical outcomes of patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia (CLL/SLL) from three studies which included Ibrutinib.
Showing 1-6 of 6